Clinical Trial Update: A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures [Phase 1, Phase 2]

View source ↗

Summary

A safety and tolerability study of nitazoxanide in individuals with HIV and hepatitis C who failed prior treatment (Phase 1/2; completed with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Nitazoxanide (nitazoxanide)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Hepatitis C Infection, HIV Infection | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-05-15